AID
Automated insulin delivery

BGM

Blood glucose monitoring

BMI

Body Mass Index

CGM

Continuous glucose monitoring

CVD

Cardiovascular disease

CSII

Continuous subcutaneous insulin infusion

DPP - inhibitors

Diabetes Prevention Program

DPP - 4

Dipeptidyl peptidase - 4 inhibitors

GLP-1Ra

Glucagon like peptide – 1 receptor agonists

GRADE

Grading of Recommendations Assessment, Development and Evaluation

HbA1c

glycated haemoglobin A1c

ICR

Insulin to carbohydrate ratio

ISF

Insulin Sensitivity Factor

LAA

Long acting analogs

MDI

Multiple daily injections

RAA

Rapid-acting analogs 

RCT

Randomized controlled trial

SGLT2i

Sodium glucose co transporter inhibitors

TDD.

Total daily insulin dose

TIR

Time in Range

URAA

Ultra rapid-acting insulin analog.